A phase 2b study evaluating repibresib gel in nonsegmental vitiligo did not meet its primary endpoint and an ongoing ...

V Foundation for Cancer Research has named Diana Hargreaves, PhD, a 2025 All-Star Translational Award Program grantee, ...

U.S. officials have rejected proposed amendments to WHO’s International Health Regulations citing concerns over vague wording ...

Once-weekly tirzepatide conferred a similar cardiovascular risk as once-weekly dulaglutide in adults with type 2 diabetes and ...

In this Healio Video Perspective from the American Society of Retina Specialists annual meeting, Sunir J. Garg, MD, FACS, ...

AbbVie released positive topline data from its phase 3 UP-AA trial demonstrating safety and efficacy for upadacitinib for ...

Exercise-based cardiac rehabilitation may improve symptom burden, exercise capacity and health-related quality of life for ...

Last winter, I donated my kidney to a stranger. As a nephrologist, I see people every day who need a gently used kidney, and ...

Daily doses of obicetrapib over 52 weeks led to significant reductions in plasma p-tau217 and other Alzheimer’s disease ...

Patients with type 2 diabetes are more likely to experience adverse financial outcomes such as having a low credit score, ...

Most children hospitalized for COVID-19 had at least one underlying condition and less than 4% were up to date on COVID-19 ...

Alcon launched Tryptyr, a treatment for the signs and symptoms of dry eye disease, in the U.S. Tryptyr (acoltremon ophthalmic solution 0.003%) is a TRPM8 receptor agonist that showed a “statistically ...